284 related articles for article (PubMed ID: 21077944)
1. Oral antiplatelet agents in ACS: from pharmacology to clinical differences.
Agewall S; Badimon L; Drouet L; Eschenhagen T; Husted S; Simon T; Steg G
Fundam Clin Pharmacol; 2011 Oct; 25(5):564-71. PubMed ID: 21077944
[TBL] [Abstract][Full Text] [Related]
2. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?
Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J
Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242
[TBL] [Abstract][Full Text] [Related]
3. Ticagrelor: a novel reversible oral antiplatelet agent.
Nawarskas JJ; Clark SM
Cardiol Rev; 2011; 19(2):95-100. PubMed ID: 21285670
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome.
Abergel E; Nikolsky E
Vasc Health Risk Manag; 2010 Oct; 6():963-77. PubMed ID: 21057581
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy in acute coronary syndrome (ACS): applying new science to clinical decisions.
Becker RC; Gibson CM; Jennings LK; Morrow DA
Am J Cardiol; 2010 Oct; 106(8):S2-3. PubMed ID: 20920638
[TBL] [Abstract][Full Text] [Related]
7. Unmet needs in oral antiplatelet therapy with ADP receptor blocking agents.
Husted S
Fundam Clin Pharmacol; 2009 Feb; 23(1):1-9. PubMed ID: 19267766
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.
Mousa SA; Jeske WP; Fareed J
Clin Appl Thromb Hemost; 2010 Apr; 16(2):170-6. PubMed ID: 20299391
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
10. Emerging oral antiplatelet therapies for acute coronary syndromes.
Pollack CV
Hosp Pract (1995); 2010 Nov; 38(4):29-37. PubMed ID: 21068524
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects and outcomes with new P2Y12 inhibitors in ACS.
Collet JP; O'Connor S
Fundam Clin Pharmacol; 2012 Feb; 26(1):16-8. PubMed ID: 21895760
[TBL] [Abstract][Full Text] [Related]
12. Developments in antiplatelet therapy for acute coronary syndromes and considerations for long-term management.
Cowley MJ; Kuritzky L
Curr Med Res Opin; 2009 Jun; 25(6):1477-90. PubMed ID: 19419337
[TBL] [Abstract][Full Text] [Related]
13. Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.
Capranzano P; Ferreiro JL; Angiolillo DJ
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):361-9. PubMed ID: 19379060
[TBL] [Abstract][Full Text] [Related]
14. Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor.
De Servi S; Navarese EP; D'Urbano M; Savonitto S
Curr Med Res Opin; 2011 Nov; 27(11):2117-22. PubMed ID: 21919581
[TBL] [Abstract][Full Text] [Related]
15. Clinical overview of promising nonthienopyridine antiplatelet agents.
Angiolillo DJ; Guzman LA
Am Heart J; 2008 Aug; 156(2 Suppl):S23-8. PubMed ID: 18657683
[TBL] [Abstract][Full Text] [Related]
16. A critical overview on ticagrelor in acute coronary syndromes.
Navarese EP; Buffon A; Kozinski M; Obonska K; Rychter M; Kunadian V; Austin D; De Servi S; Sukiennik A; Kubica J
QJM; 2013 Feb; 106(2):105-15. PubMed ID: 23097390
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet function variability in clopidogrel-treated patients: need for new antiplatelet agents.
Höchtl T; Tentzeris I; Schrör K; Huber K
Fundam Clin Pharmacol; 2012 Feb; 26(1):2-10. PubMed ID: 21831128
[TBL] [Abstract][Full Text] [Related]
18. Triple antiplatelet therapy in acute coronary syndromes.
Valgimigli M; Minarelli M
Drugs; 2011 Sep; 71(13):1703-19. PubMed ID: 21902293
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor, a platelet aggregation inhibitor for the potential prevention and treatment of arterial thrombosis and acute coronary syndromes.
Doggrell SA
IDrugs; 2009 May; 12(5):309-17. PubMed ID: 19431096
[TBL] [Abstract][Full Text] [Related]
20. Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies.
Steinhubl SR
Rev Cardiovasc Med; 2006; 7 Suppl 4():S12-9. PubMed ID: 17224886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
